University of California San Francisco
Give to UCSF
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
The annual U.S. News rankings serve as a guide of hospitals nationwide that excel in treating children with the most challenging diagnoses.
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
As cases of COVID-19 continue to mount in Navajo Nation, UC San Francisco is sending a second team of health care workers — 13 nurses and six physicians — to Arizona to help provide urgently needed support to the largest hospitals serving Navajo patients.
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.
New research confirmed the higher rates of early life respiratory infections among Puerto Ricans.
UCSF is launching a workforce training and technical assistance program in partnership with the California Department of Public Health to facilitate the training of thousands of individuals across the state in public health techniques and strategies, including contact tracing, case investigation and administration, to limit the ongoing spread of COVID-19.
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
To ramp up contact tracing for COVID-19 in San Francisco, UCSF has been partnering with the San Francisco Department of Public Health (SFDPH) to provide technical assistance, training and manpower.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
